{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:58:31Z","timestamp":1795089511785,"version":"4.10.2"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Pharos University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The main focus of our study is to assess the anti-cancer activity of cimetidine and vitamin C via combating the tumor supportive role of mast cell mediators (histamine, VEGF, and TNF-\u03b1) within the tumor microenvironment and their effect on the protein kinase A(PKA)\/insulin receptor substrate-1(IRS-1)\/phosphatidylinositol-3-kinase (PI3K)\/serine\/threonine kinase-1 (AKT)\/mammalian target of rapamycin (mTOR) cue in Ehrlich induced breast cancer in mice. In vitro study was carried out to evaluate the anti-proliferative activity and combination index (CI) of the combined drugs. Moreover, the Ehrlich model was induced in mice via subcutaneous injection of Ehrlich ascites carcinoma cells (EAC) in the mammary fat pad, and then they were left for 9\u00a0days to develop obvious solid breast tumor. The combination therapy possessed the best anti-proliferative effect, and a CI\u2009&lt;\u20091 in the MCF7 cell line indicates a synergistic type of drug interaction. Regarding the in vivo study, the combination abated the elevation in the tumor volume, and serum tumor marker carcinoembryonic antigen (CEA) level. The serum vascular endothelial growth factor (VEGF) level and immunohistochemical staining for CD34 as markers of angiogenesis were mitigated. Additionally, it reverted the state of oxidative stress and inflammation. Meanwhile, it caused an increment in apoptosis, which prevents tumor survival. Furthermore, it tackled the elevated histamine and cyclic adenosine monophosphate (cAMP) levels, preventing the activation of the (PKA\/IRS-1\/PI3K\/AKT\/mTOR) cue. Finally, we concluded that the synergistic combination provided a promising anti-neoplastic effect via reducing the angiogenesis, oxidative stress, increasing apoptosis,as well as inhibiting the activation of PI3K\/AKT\/mTOR cue, and suggesting its use as a treatment option for breast cancer.<\/jats:p>","DOI":"10.1038\/s41598-022-15551-6","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T13:08:02Z","timestamp":1657199282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Anti-neoplastic action of Cimetidine\/Vitamin C on histamine and the PI3K\/AKT\/mTOR pathway in Ehrlich breast cancer"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3467-5172","authenticated-orcid":false,"given":"Sherihan Salaheldin Abdelhamid","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A. Abd","family":"El-Aal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Reda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar El","family":"Achy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Shahine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"issue":"11","key":"15551_CR1","first-page":"4464","volume":"4","author":"A Yousafzai","year":"2017","unstructured":"Yousafzai, A. et al. Clinical presentation and lifestyle related risk factors of breast cancer among different age and ethnic groups. Indo Am. J. Pharm. Sci. 4(11), 4464\u20134475 (2017).","journal-title":"Indo Am. J. Pharm. Sci."},{"key":"15551_CR2","doi-asserted-by":"publisher","first-page":"5162687","DOI":"10.1155\/2019\/5162687","volume":"2019","author":"MA Aldubayan","year":"2019","unstructured":"Aldubayan, M. A., Elgharabawy, R. M., Ahmed, A. S. & Tousson, E. Antineoplastic activity and curative role of avenanthramides against the growth of ehrlich solid tumors in mice. Oxid. Med. Cell Longev. 2019, 5162687. https:\/\/doi.org\/10.1155\/2019\/5162687 (2019).","journal-title":"Oxid. Med. Cell Longev."},{"key":"15551_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2020.02.006","volume":"106","author":"G Bahcecioglu","year":"2020","unstructured":"Bahcecioglu, G., Basara, G., Ellis, B. W., Ren, X. & Zorlutuna, P. Breast cancer models: Engineering the tumor microenvironment. Acta Biomater. 106, 1\u201321. https:\/\/doi.org\/10.1016\/j.actbio.2020.02.006 (2020).","journal-title":"Acta Biomater."},{"key":"15551_CR4","doi-asserted-by":"publisher","first-page":"2584243","DOI":"10.1155\/2018\/2584243","volume":"2018","author":"A Aponte-L\u00f3pez","year":"2018","unstructured":"Aponte-L\u00f3pez, A., Fuentes-Panan\u00e1, E. M., Cortes-Mu\u00f1oz, D. & Mu\u00f1oz-Cruz, S. Mast cell, the neglected member of the tumor microenvironment: Role in breast cancer. J. Immunol. Res. 2018, 2584243. https:\/\/doi.org\/10.1155\/2018\/2584243 (2018).","journal-title":"J. Immunol. Res."},{"issue":"1","key":"15551_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.molimm.2014.02.020","volume":"63","author":"SA Oldford","year":"2015","unstructured":"Oldford, S. A. & Marshall, J. S. Mast cells as targets for immunotherapy of solid tumors. Mol. Immunol. 63(1), 113\u2013124. https:\/\/doi.org\/10.1016\/j.molimm.2014.02.020 (2015).","journal-title":"Mol. Immunol."},{"key":"15551_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173747","volume":"892","author":"RM Hazem","year":"2021","unstructured":"Hazem, R. M. et al. Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma. Eur. J. Pharmacol. 892, 173747. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173747 (2021).","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"15551_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/bph.14535","volume":"177","author":"NA Massari","year":"2020","unstructured":"Massari, N. A., Nicoud, M. B. & Medina, V. A. Histamine receptors and cancer pharmacology: An update. Br. J. Pharmacol. 177(3), 516\u2013538. https:\/\/doi.org\/10.1111\/bph.14535 (2020).","journal-title":"Br. J. Pharmacol."},{"issue":"33","key":"15551_CR8","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.2174\/0929867324666170711114336","volume":"25","author":"H Gurer-Orhan","year":"2018","unstructured":"Gurer-Orhan, H., Ince, E., Konyar, D., Saso, L. & Suzen, S. The role of oxidative stress modulators in breast cancer. Curr. Med. Chem. 25(33), 4084\u20134101. https:\/\/doi.org\/10.2174\/0929867324666170711114336 (2018).","journal-title":"Curr. Med. Chem."},{"issue":"11","key":"15551_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/biom9110735","volume":"9","author":"V Aggarwal","year":"2019","unstructured":"Aggarwal, V. et al. Role of reactive oxygen species in cancer progression: Molecular mechanisms and recent advancements. Biomolecules 9(11), 735. https:\/\/doi.org\/10.3390\/biom9110735 (2019).","journal-title":"Biomolecules"},{"issue":"8","key":"15551_CR10","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/biom11081232","volume":"11","author":"PL Nguyen","year":"2021","unstructured":"Nguyen, P. L. & Cho, J. Pathophysiological roles of histamine receptors in cancer progression: Implications and perspectives as potential molecular targets. Biomolecules 11(8), 1232. https:\/\/doi.org\/10.3390\/biom11081232 (2021).","journal-title":"Biomolecules"},{"issue":"53","key":"15551_CR11","doi-asserted-by":"publisher","first-page":"27160","DOI":"10.1074\/jbc.M116.763235","volume":"291","author":"NC Law","year":"2016","unstructured":"Law, N. C., White, M. F. & Hunzicker-Dunn, M. E. G protein-coupled receptors (GPCRs) that signal via protein kinase A (PKA) cross-talk at insulin receptor substrate 1 (IRS1) to activate the phosphatidylinositol 3-kinase (PI3K)\/AKT pathway. J. Biol. Chem. 291(53), 27160\u201327169. https:\/\/doi.org\/10.1074\/jbc.M116.763235 (2016).","journal-title":"J. Biol. Chem."},{"issue":"2","key":"15551_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3892\/ijo.2016.3558","volume":"49","author":"N Pilco-Ferreto","year":"2016","unstructured":"Pilco-Ferreto, N. & Calaf, G. M. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. Int. J. Oncol. 49(2), 753\u2013762 (2016).","journal-title":"Int. J. Oncol."},{"issue":"5","key":"15551_CR13","first-page":"1021","volume":"28","author":"F Lefranc","year":"2006","unstructured":"Lefranc, F., Yeaton, P., Brotchi, J. & Kiss, R. Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review). Int. J. Oncol. 28(5), 1021\u20131030 (2006) (PMID: 16596218).","journal-title":"Int. J. Oncol."},{"issue":"5","key":"15551_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejps.2011.02.004","volume":"42","author":"M Kubecova","year":"2011","unstructured":"Kubecova, M., Kolostova, K., Pinterova, D., Kacprzak, G. & Bobek, V. Cimetidine: An anti-cancer drug?. Eur. J. Pharm. Sci. 42(5), 439\u2013444. https:\/\/doi.org\/10.1016\/j.ejps.2011.02.004 (2011).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"15551_CR15","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1038\/s41598-018-23714-7","volume":"8","author":"DW Sant","year":"2018","unstructured":"Sant, D. W. et al. Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression. Sci. Rep. 8(1), 5306. https:\/\/doi.org\/10.1038\/s41598-018-23714-7 (2018).","journal-title":"Sci. Rep."},{"issue":"2","key":"15551_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.21873\/anticanres.13172","volume":"39","author":"SJ Lee","year":"2019","unstructured":"Lee, S. J. et al. Effect of high-dose Vitamin C combined with anti-cancer treatment on breast cancer cells. Anticancer Res. 39(2), 751\u2013758. https:\/\/doi.org\/10.21873\/anticanres.13172 (2019).","journal-title":"Anticancer Res."},{"key":"15551_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","volume":"731","author":"J Van Meerloo","year":"2011","unstructured":"Van Meerloo, J., Kaspers, G. J. L. & Cloos, J. Cell sensitivity assays: The MTT assay. Methods Mol. Biol. 731, 237\u2013245. https:\/\/doi.org\/10.1007\/978-1-61779-080-5_20 (2011).","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"15551_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/s1734-1140(13)71021-1","volume":"65","author":"GS Wu","year":"2013","unstructured":"Wu, G. S. et al. Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells. Pharmacol. Rep. 65(2), 453\u2013459. https:\/\/doi.org\/10.1016\/s1734-1140(13)71021-1 (2013).","journal-title":"Pharmacol. Rep."},{"issue":"11","key":"15551_CR19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jnutbio.2010.09.009","volume":"22","author":"AL Miranda-Vilela","year":"2011","unstructured":"Miranda-Vilela, A. L. et al. The protective effects of nutritional antioxidant therapy on Ehrlich solid tumor bearing mice depend on the type of antioxidant therapy chosen: Histology, genotoxicity and hematology evaluations. J. Nutr. Biochem. 22(11), 1091\u20131098 (2011).","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"15551_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12951-019-0445-7","volume":"17","author":"DG Zayed","year":"2019","unstructured":"Zayed, D. G. et al. Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin-QDs nano-hybrids: Covalent coupling and phospholipid complexation approaches. J Nanobiotechnol. 17(1), 7. https:\/\/doi.org\/10.1186\/s12951-019-0445-7 (2019).","journal-title":"J Nanobiotechnol."},{"issue":"12","key":"15551_CR21","doi-asserted-by":"publisher","first-page":"9267","DOI":"10.1007\/s13277-015-3655-0","volume":"36","author":"NF Khedr","year":"2015","unstructured":"Khedr, N. F. & Khalil, R. M. Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin. Tumour Biol. 36(12), 9267\u20139275. https:\/\/doi.org\/10.1007\/s13277-015-3655-0 (2015).","journal-title":"Tumour Biol."},{"issue":"6","key":"15551_CR22","first-page":"907","volume":"4","author":"C Fiorini","year":"2014","unstructured":"Fiorini, C. et al. Methods to identify molecular expression of mTOR pathway: A rational approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. Am. J. Cancer Res. 4(6), 907\u2013915 (2014).","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"15551_CR23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12291-013-0375-3","volume":"28","author":"S Chambial","year":"2013","unstructured":"Chambial, S., Dwivedi, S., Shukla, K. K., John, P. J. & Sharma, P. Vitamin C in disease prevention and cure: An overview. Indian J. Clin. Biochem. 28(4), 314\u2013328. https:\/\/doi.org\/10.1007\/s12291-013-0375-3 (2013).","journal-title":"Indian J. Clin. Biochem."},{"issue":"5","key":"15551_CR24","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.3892\/etm.2016.3707","volume":"12","author":"G Wang","year":"2016","unstructured":"Wang, G., Yin, T. & Wang, Y. In vitro and in vivo assessment of high-dose vitamin C against murine tumors. Exp. Ther. Med. 12(5), 3058\u20133062. https:\/\/doi.org\/10.3892\/etm.2016.3707 (2016).","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"15551_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.freeradbiomed.2009.02.016","volume":"47","author":"J Verrax","year":"2009","unstructured":"Verrax, J. & Calderon, P. B. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radic. Biol. Med. 47(1), 32\u201340. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.02.016 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"15551_CR26","doi-asserted-by":"publisher","first-page":"11105","DOI":"10.1073\/pnas.0804226105","volume":"105","author":"Q Chen","year":"2008","unstructured":"Chen, Q. et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl. Acad. Sci. USA 105, 11105\u201311109. https:\/\/doi.org\/10.1073\/pnas.0804226105 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"15551_CR27","first-page":"2375","volume":"10","author":"M Ozaslan","year":"2011","unstructured":"Ozaslan, M., Karagoz, I. D., Kilic, I. H. & Guldur, M. E. Ehrlich ascites carcinoma. Afr. J. Biotechnol. 10(13), 2375\u20132378 (2011).","journal-title":"Afr. J. Biotechnol."},{"issue":"6","key":"15551_CR28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1365-2559.2007.02869.x","volume":"51","author":"D Ribatti","year":"2007","unstructured":"Ribatti, D. et al. Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastases. Histopathology 51(6), 837\u2013842. https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02869.x (2007).","journal-title":"Histopathology"},{"issue":"4","key":"15551_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1046\/j.1365-2168.1998.00625","volume":"85","author":"JL Reynolds","year":"1998","unstructured":"Reynolds, J. L. et al. Histamine in human breast cancer. Br. J. Surg. 85(4), 538\u2013541. https:\/\/doi.org\/10.1046\/j.1365-2168.1998.00625 (1998).","journal-title":"Br. J. Surg."},{"issue":"12","key":"15551_CR30","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/nm1295-1243","volume":"1","author":"DL Morris","year":"1995","unstructured":"Morris, D. L. & Adams, W. J. Cimetidine and colorectal cancer\u2013old drug, new use?. Nat. Med. 1(12), 1243\u20131244. https:\/\/doi.org\/10.1038\/nm1295-1243 (1995).","journal-title":"Nat. Med."},{"issue":"1","key":"15551_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41416-018-0173-z","volume":"120","author":"HA Sterle","year":"2019","unstructured":"Sterle, H. A. et al. Immunomodulatory role of histamine H4 receptor in breast cancer. Br. J. Cancer. 120(1), 128\u2013138. https:\/\/doi.org\/10.1038\/s41416-018-0173-z (2019).","journal-title":"Br. J. Cancer."},{"key":"15551_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/978-1-4939-6843-5_12","volume-title":"Histamine receptors as drug targets","author":"DJ Martinel Lamas","year":"2017","unstructured":"Martinel Lamas, D. J. et al. Methodological approaches to investigate the effects of histamine receptor targeting compounds in preclinical models of breast cancer. In Histamine receptors as drug targets 353\u2013387 (Springer, 2017)."},{"issue":"1","key":"15551_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2217\/pgs.14.148","volume":"16","author":"A Koutras","year":"2015","unstructured":"Koutras, A., Kotoula, V. & Fountzilas, G. Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer. Pharmacogenomics 16(1), 79\u201394. https:\/\/doi.org\/10.2217\/pgs.14.148 (2015).","journal-title":"Pharmacogenomics"},{"issue":"2","key":"15551_CR34","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3892\/ol.2015.3348","volume":"10","author":"Z Chen","year":"2015","unstructured":"Chen, Z. et al. Expression of cluster of differentiation 34 and vascular endothelial growth factor in breast cancer, and their prognostic significance. Oncol. Lett. 10(2), 723\u2013729. https:\/\/doi.org\/10.3892\/ol.2015.3348 (2015).","journal-title":"Oncol. Lett."},{"issue":"11","key":"15551_CR35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/PL00012428","volume":"51","author":"HJ Nielsen","year":"2002","unstructured":"Nielsen, H. J. et al. Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis. Inflamm. Res. 51(11), 563\u2013567 (2002).","journal-title":"Inflamm. Res."},{"issue":"19","key":"15551_CR36","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.1158\/1078-0432.CCR-05-0675","volume":"11","author":"F Cianchi","year":"2005","unstructured":"Cianchi, F. et al. The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin. Cancer Res. 11(19), 6807 (2005).","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"15551_CR37","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/sj.bjp.0704372","volume":"134","author":"AK Ghosh","year":"2001","unstructured":"Ghosh, A. K., Hirasawa, N. & Ohuchi, K. Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors. Br. J. Pharmacol. 134(7), 1419\u20131428. https:\/\/doi.org\/10.1038\/sj.bjp.0704372 (2001).","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"15551_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1254\/jphs.93.321","volume":"93","author":"K Tomita","year":"2003","unstructured":"Tomita, K., Izumi, K. & Okabe, S. Roxatidine- and cimetidine-induced angiogenesis inhibition suppresses growth of colon cancer implants in syngeneic mice. J Pharmacol Sci. 93(3), 321\u2013330. https:\/\/doi.org\/10.1254\/jphs.93.321 (2003).","journal-title":"J Pharmacol Sci."},{"issue":"3","key":"15551_CR39","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/jcb.22997","volume":"112","author":"HN Kim","year":"2011","unstructured":"Kim, H. N. et al. Vitamin C down-regulates VEGF production in B16F10 murine melanoma cells via the suppression of p42\/44 MAPK activation. J. Cell Biochem. 112(3), 894\u2013901. https:\/\/doi.org\/10.1002\/jcb.22997 (2011).","journal-title":"J. Cell Biochem."},{"issue":"6","key":"15551_CR40","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1248\/bpb.b21-00089","volume":"44","author":"K Nakanishi","year":"2021","unstructured":"Nakanishi, K., Hiramoto, K. & Ooi, K. High-dose vitamin C exerts its anti-cancer effects in a xenograft model of colon cancer by suppressing angiogenesis. Biol. Pharm. Bull. 44(6), 884\u2013887. https:\/\/doi.org\/10.1248\/bpb.b21-00089 (2021).","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"15551_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","volume":"43","author":"D Cruceriu","year":"2020","unstructured":"Cruceriu, D., Baldasici, O., Balacescu, O. & Berindan-Neagoe, I. The dual role of tumor necrosis factor-alpha (TNF-\u03b1) in breast cancer: Molecular insights and therapeutic approaches. Cell Oncol. (Dordr). 43(1), 1\u201318. https:\/\/doi.org\/10.1007\/s13402-019-00489-1 (2020).","journal-title":"Cell Oncol. (Dordr)."},{"key":"15551_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/426740","volume":"2014","author":"Y Chen","year":"2014","unstructured":"Chen, Y. et al. Vitamin C mitigates oxidative stress and tumor necrosis factor-alpha in severe community-acquired pneumonia and LPS-induced macrophages. Mediators Inflamm. 2014, 426740. https:\/\/doi.org\/10.1155\/2014\/426740 (2014).","journal-title":"Mediators Inflamm."},{"key":"15551_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104271","volume":"75","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Wheat peptide protects against ethanol-induced gastric mucosal damage through downregulation of TLR4 and MAPK. J. Funct. Foods 75, 104271 (2020).","journal-title":"J. Funct. Foods"},{"issue":"12","key":"15551_CR44","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3389\/fimmu.2021.656908","volume":"27","author":"D Laha","year":"2021","unstructured":"Laha, D., Grant, R., Mishra, P. & Nilubol, N. The role of tumor necrosis factor in manipulating the immunological response of tumor microenvironment. Front. Immunol. 27(12), 1415. https:\/\/doi.org\/10.3389\/fimmu.2021.656908 (2021).","journal-title":"Front. Immunol."},{"issue":"5","key":"15551_CR45","first-page":"11","volume":"13","author":"AT Ellethy","year":"2019","unstructured":"Ellethy, A. T. Potential anti-tumor activity of nonsteroidal anti-inflammatory drugs against Ehrlich ascites carcinoma in experimental animals. Int. J. Health Sci. (Qassim). 13(5), 11\u201317 (2019).","journal-title":"Int. J. Health Sci. (Qassim)."},{"issue":"2","key":"15551_CR46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejbas.2015.02.003","volume":"2","author":"DA Ali","year":"2018","unstructured":"Ali, D. A., Badr El-Din, N. K. & Abou-El-magd, R. F. Antioxidant and hepatoprotective activities of grape seeds and skin against Ehrlich solid tumor induced oxidative stress in mice. Egypt. J. Basic Appl. Sci. 2(2), 98\u2013109. https:\/\/doi.org\/10.1016\/j.ejbas.2015.02.003 (2018).","journal-title":"Egypt. J. Basic Appl. Sci."},{"key":"15551_CR47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.11855\/j.issn.0577-7402.2017.02.07","volume":"12","author":"YN Zhao","year":"2017","unstructured":"Zhao, Y. N. et al. Protective effects of cimetidine against oxidative stress induced by low-dose irradiation. Med. J. Chin. People\u2019s Lib. Army 12, 128\u2013133. https:\/\/doi.org\/10.11855\/j.issn.0577-7402.2017.02.07 (2017).","journal-title":"Med. J. Chin. People\u2019s Lib. Army"},{"issue":"1","key":"15551_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5001\/omj.2014.09","volume":"29","author":"MM Mahmoudabadi","year":"2014","unstructured":"Mahmoudabadi, M. M. & Rahbar, A. R. Effect of EPA and vitamin C on superoxide dismutase, glutathione peroxidase, total antioxidant capacity and malondialdehyde in type 2 diabetic patients. Oman Med. J. 29(1), 39\u201345. https:\/\/doi.org\/10.5001\/omj.2014.09 (2014).","journal-title":"Oman Med. J."},{"issue":"2","key":"15551_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1556\/2060.104.2017.2.5","volume":"104","author":"M Savran","year":"2017","unstructured":"Savran, M. et al. Vitamin C attenuates methotrexate-induced oxidative stress in kidney and liver of rats. Physiol. Int. 104(2), 139\u2013149 (2017).","journal-title":"Physiol. Int."},{"key":"15551_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fonc.2014.00064","volume":"4","author":"C Porta","year":"2014","unstructured":"Porta, C., Paglino, C. & Mosca, A. Targeting PI3K\/Akt\/mTOR signaling in cancer. Front. Oncol. 4, 64. https:\/\/doi.org\/10.3389\/fonc.2014.00064 (2014).","journal-title":"Front. Oncol."},{"key":"15551_CR51","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fonc.2018.00160","volume":"8","author":"N Koundouros","year":"2018","unstructured":"Koundouros, N. & Poulogiannis, G. Phosphoinositide 3-kinase\/Akt signaling and redox metabolism in cancer. Front. Oncol. 8, 160. https:\/\/doi.org\/10.3389\/fonc.2018.00160 (2018).","journal-title":"Front. Oncol."},{"issue":"4","key":"15551_CR52","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00280-016-3006-x","volume":"77","author":"P Borentain","year":"2016","unstructured":"Borentain, P. et al. Inhibition of E-selectin expression on the surface of endothelial cells inhibits hepatocellular carcinoma growth by preventing tumor angiogenesis. Cancer Chemother. Pharmacol. 77(4), 847\u2013856. https:\/\/doi.org\/10.1007\/s00280-016-3006-x (2016).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"15551_CR53","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3892\/or_00000686","volume":"23","author":"CG Jiang","year":"2010","unstructured":"Jiang, C. G., Liu, F. R., Yu, M., Li, J. B. & Xu, H. M. Cimetidine induces apoptosis in gastric cancer cells in vitro and inhibits tumor growth in vivo. Oncol. Rep. 23(3), 693\u2013700. https:\/\/doi.org\/10.3892\/or_00000686 (2010).","journal-title":"Oncol. Rep."},{"issue":"1","key":"15551_CR54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13148-018-0527-7","volume":"10","author":"D Peng","year":"2018","unstructured":"Peng, D. et al. Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer. Clin. Epigenet. 10(1), 94. https:\/\/doi.org\/10.1186\/s13148-018-0527-7 (2018).","journal-title":"Clin. Epigenet."},{"issue":"1","key":"15551_CR55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.21608\/bvmj.2018.54257","volume":"34","author":"OM Abdel-Hamid","year":"2018","unstructured":"Abdel-Hamid, O. M., Nafee, A. A., Emam, M. A. & Elshimaa, M. A. The ameliorative effect of Vitamin C in experimentally induced colon cancer in rats. Benha Vet. Med. J. 34(1), 329\u2013343. https:\/\/doi.org\/10.21608\/bvmj.2018.54257 (2018).","journal-title":"Benha Vet. Med. J."},{"key":"15551_CR56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/1479-5876-10-189","volume":"10","author":"N Mikirova","year":"2012","unstructured":"Mikirova, N., Casciari, J., Rogers, A. & Taylor, P. Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J. Transl. Med. 10, 189. https:\/\/doi.org\/10.1186\/1479-5876-10-189 (2012).","journal-title":"J. Transl. Med."},{"issue":"57","key":"15551_CR57","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1038\/sj.onc.1206044","volume":"21","author":"E Devarajan","year":"2002","unstructured":"Devarajan, E. et al. Down-regulation of caspase 3 in breast cancer: A possible mechanism for chemoresistance. Oncogene 21(57), 8843\u20138851. https:\/\/doi.org\/10.1038\/sj.onc.1206044 (2002).","journal-title":"Oncogene"},{"key":"15551_CR58","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3389\/fonc.2020.00976","volume":"10","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. Vitamin C promotes apoptosis and cell cycle arrest in oral squamous cell carcinoma. Front. Oncol. 10, 976. https:\/\/doi.org\/10.3389\/fonc.2020.00976 (2020).","journal-title":"Front. Oncol."},{"key":"15551_CR59","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1155\/2019\/7286737","volume":"24","author":"E Pawlowska","year":"2019","unstructured":"Pawlowska, E., Szczepanska, J. & Blasiak, J. Pro-and antioxidant effects of vitamin C in cancer in correspondence to its dietary and pharmacological concentrations. Oxid. Med. Cell. Longev. 24, 2019. https:\/\/doi.org\/10.1155\/2019\/7286737 (2019).","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15551-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15551-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15551-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:40:42Z","timestamp":1669358442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15551-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15551"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15551-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"assertion":[{"value":"26 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11514"}}